Published in Cardiovascular Business Week, July 6th, 2004
This measurement, known as the RNA integrity number (RIN), makes it possible for scientists to objectively measure and communicate the quality of RNA used in experiments, a critical need in the development of advanced therapeutics for cancer and cardiovascular disease.
Until now, scientists have been unable to reliably compare the quality of RNA - a genetic molecule used extensively in biological research - between experiments or across laboratories.
This limitation has greatly inhibited the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.